| Similar Articles |
|---|
 |
Reason
April 2003
Melinda Ammann |
The Agony and the Ecstasy How the OxyContin crackdown hurts patients in pain   |
Reason
September 2004
Maia Szalavitz |
Dr. Feelscared U.S. drug warriors put the fear of prosecution in physicians who dare to treat pain. While the OxyContin panic does not seem to have deterred addicts, it has scared doctors. |
BusinessWeek
January 17, 2005
Catherine Arnst |
No Pain, Some Gain The 50 million Americans suffering from chronic pain got a little bit of good news in December. The Food & Drug Administration greenlighted two new medications that attack pain in completely novel ways. |
Pharmaceutical Executive
June 1, 2011
Jill Wechsler |
Educating Physicians A communications program is the main component of a Risk Evaluation and Mitigation Strategy to promote safe use of extended-release or long-acting opioids, which have been the subject of FDA/industry negotiations for several years. |
The Motley Fool
July 24, 2007
Brian Lawler |
Pain and Alpharma Gain From Purdue's Slip Purdue Frederick Company pays a high price for misleading the public about its pain drug OxyContin; other drugmakers stand to benefit from it. |
Nursing
October 2009
Yvonne D'Arcy |
Overturning barriers to pain relief in older adults This article will describe how to lower the barriers to effective pain control in older patients and provide practical tips for helping them receive the full benefit from pharmacologic and nonpharmacologic therapies. |
American Family Physician
May 15, 2001 |
Pain Relief After Surgery How will my pain be managed?...How are pain medicines given after surgery?... What should I do to make sure I receive the best possible pain relief?... |
Managed Care
October 2003
Martin Sipkoff |
Pain Management: Health Plans Need to Take Control Insurers have not focused much on chronic pain. They should. It presents a humanitarian and business opportunity. |
Nursing
June 2008
Yvonne D'arcy |
Nursing2008 Pain Management Survey Report See how your responses to this survey compare with those of nursing colleagues across the country and beyond. |
Wired
April 2005
Douglas McGray |
The Bitter Pill Buprenorphine could end heroin addiction, curb disease, and cut crime. But bureaucrats, doctors, and much of the treatment industry are just saying no. A case study in why the best technology doesn't always win. |
Reason
February 2005
Jacob Sullum |
Disappearing Docs Doctors have been fighting the "opiophobia" that leads to widespread undertreatment of pain for many years. But it was surprising to see them endorsed by the DEA, which has long insisted there is no conflict between drug control and pain control. |
Health
June 2007
Melanie Haiken |
The Best New Pain Cures?... For Women New research shows that pain can often be prevented if women use the right treatment. Here's what you should know. |
BusinessWeek
December 18, 2006
Keith Epstein |
The Deadly Side Effects of Net Pharmacies Operating in a legal grey area, their doctors write thousands of prescriptions for people, sight unseen. Is better regulation required? |
Health
May 2007
Melanie Haiken |
Smart Ways to Banish Pain Women are not small men when it comes to pain treatment. Here are better options for women: Antidepressants... Neuropathic pain relievers... etc. |
Pharmaceutical Executive
December 1, 2013 |
FDA Pursues Delicate Balancing Act The Agency struggles to ensure access to needed medicines while minimizing potential risks, writes Jill Wechsler. |
The Motley Fool
April 26, 2011
Brian Orelli |
We Hate Your Drug. And That's a Good Thing. This one's a pain for the clinical trial participants. |
Pharmaceutical Executive
July 1, 2009
Jill Wechsler |
Safety and Security As FDA looks to balance risks and benefits, more regulations are on the horizon. |
American Journal of Nursing
April 2010
Mary Curry Narayan |
Culture's Effects on Pain Assessment and Management When patients belong to a culture or speak a language that's different from that of their health care provider, the provider faces additional challenges in successfully assessing and managing the patients' pain. |
The Motley Fool
October 5, 2007
Brian Lawler |
OxyContin in the Crosshairs Again The state of Kentucky sues Purdue Frederick over the monetary burden that abusers of the drug OxyContin place on counties within the state. |
Salon.com
October 18, 2000
Cynthia Kuhn & Wilkie Wilson |
Hooked on painkillers My doctor prescribed narcotics after my accident and now I can't get off them. What should I do? |
Nurse Practitioner
May 2009
Yvonne D'Arcy |
Is Low Back Pain Getting on Your Nerves? The pain and disability of low back pain are the most common reasons patients seek healthcare. Here are tools for diagnosis and treatment options. |
BusinessWeek
June 14, 2004
Gene G. Marcial |
From Pain Therapeutics: A Better Pain Killer Remoxy, now in proof-of-concept trials, could become the replacement for the most popular opioid pain killer OxyContin, with a potential $1 billion market. |
Nurse Practitioner
December 2011 |
Managing pain in obese patients Obesity-related pain conditions can limit the patient's efforts at increasing activity and limit quality of life. This article will offer information on these conditions and treatment options. |
Reason
July 2003 |
Letters Pain and Relief... Boob Tube Power... Comic Warrior... Porous Border |
Pharmaceutical Executive
April 1, 2011 |
Off-Label But On Point? Use of off-label drugs is a balancing act for physicians, and poses even more problems for pharma. The FDA is moving slowly to help. |
American Family Physician
October 1, 2001
Karl E. Miller |
Challenges in Pain Management at the End of Life Effective pain management in the terminally ill patient requires an understanding of pain control strategies. Ongoing assessment of pain is crucial and can be accomplished using various forms and scales... |
Nursing Management
March 2012
Yvonne D'Arcy |
Pain and obesity It can be a challenge to provide effective pain management for obese patients; however, a multimodal pain management regimen that combines medications and complementary techniques can help increase pain relief. |
The Motley Fool
March 30, 2005
David Nierengarten |
Soothing Results, But Pain for Investors Pain Therapeutics delivers again but its stock barely budged. What gives? |
American Journal of Nursing
March 2011
Jablonski et al. |
The Use of Algorithms in Assessing and Managing Persistent Pain in Older Adults This article introduces readers to the use of algorithms in guiding the assessment and management of persistent pain in older adults, and provides an illustrative case study. |
American Family Physician
April 1, 2005
Toombs & Kral |
Methadone Treatment for Pain States Recently, methadone has been used to manage cancer pain and other chronic pain states. Its unique pharmacokinetics and pharmacodynamics make methadone a valuable option, but physicians should be aware of possible side effects. |
American Family Physician
May 1, 2006 |
Opioid Addiction: What You Should Know A consumer handout: What are opioids?... What is opioid addiction?... What can I do if I am addicted?... Where can I get more information?... |
The Motley Fool
February 25, 2010
Brian Orelli |
An Untouched Market Waiting to Be Captured Unfilled prescriptions are a potential boon to drug companies. |
Managed Care
July 2000
John Carroll |
Physicians Reconsider Taking On Pharmacy Risk They've been burned here in the past, but physicians - and the HMOs that they contract with - may have learned some lessons. |
Salon.com
October 2, 2000
Lynn O'Dell |
Pain in the brain The good news? The hurt is all in your mind. The bad news? The hurt is all in your mind... |
BusinessWeek
January 21, 2010
John Carey |
Making Personalized Medicine Pay Medco and other pharmacy benefit managers say future profits depend on matching drugs to patients based on their genes. |
The Motley Fool
May 19, 2007
Elizabeth Brokamp |
Save Big on Prescriptions Tips for cutting medication costs. |
Managed Care
April 2000
Tim Olsen |
Physician, Tarnish Not Thine Image Doctors who use the news media to criticize others, rather than initiate a constructive dialog about difficult issues such as antibiotic resistance, help erode the profession's influence. |
The Motley Fool
November 5, 2010
Brian Orelli |
Better Late Than Never for Cymbalta Eli Lilly gets an expanded approval for Cymbalta. |
Scientific American
January 2009
Jessica Wapner |
Hurdles Facing Unused Prescription Drug Repositories State-legislated programs for the donation of unused drugs have seen limited success |
BusinessWeek
November 12, 2009
Catherine Arnst |
10 Ways to Cut Health-Care Costs Right Now Employers and hospitals don't have to wait for Congress to address inefficiencies and waste. |
Pharmaceutical Executive
August 1, 2011
Jennifer Ringler |
The Adherence Fight: A TKO? Why does the match against medicines compliance always seem to end in an easy knockout? |
Fast Company
September 2010
Heath & Heath |
Dan and Chip Heath Say Nix Ambiguity and Focus for Lasting Change To succeed on the path to change you have to eliminate ambiguity. |
Wired
January 2005
Joshua Davis |
Instant Detox Kick heroin in 24 hours - no willpower, withdrawal, or preaching required. Call it a cure. Call it junk science. Call it the one-step program. |
Nurse Practitioner
May 2012
Hammersla & Kapustin |
Peripheral Neuropathy: Evidence-based treatment of a complex disorder Peripheral neuropathy is a common and often progressive condition frequently seen in primary care. The chronic pain associated with PN, or neuropathic pain, can significantly diminish patients' quality of life and be challenging to treat. |
Pharmaceutical Executive
June 1, 2014
Ben Comer |
Take as Directed: From Force to Finesse in Promoting Adherence Healthcare players tout patient education and engagement as the keys to better drug adherence rates. Patients agree, as long as that translates to convenient and affordable access to therapy. |
The Motley Fool
May 29, 2007
Brian Lawler |
The One Development-Stage Drug Stock to Own Now With such a low level of Remoxy sales baked into its share price, and minimal clinical trial risk, investors who consider Pain Therapeutics around today's share price won't be hurting in the long run, if you assume there will be a viable market for abuse-resistant opioids. |
Managed Care
May 2005 |
Microcircuit Devices Deliver Considerable Relief From Chronic Pain Recent advances in pain relief revolve around longer-lasting implantable devices. Can managed care afford not to have a pain management strategy? |
Pharmaceutical Executive
July 1, 2005
Patrick Clinton |
Playing Doctor Why Congress plans to ban erectile dysfunction drugs from Medicare and Medicaid, and why they shouldn't do it. |
American Journal of Nursing
April 2009 |
Understanding and Managing Burn Pain: Part 1 Despite advances in topical wound care and pharmacology, and a growing emphasis on palliative care, wound care is the main source of the pain associated with burn injury. |
The Motley Fool
May 10, 2011
Brian Orelli |
Uncontrolled Crying Over AVANIR's Prescription Data? It's been a slow start, but don't write off this company's pseudobulbar drug just yet. |
